At the present time, there is no universal consensus on which AF patients should undergo catheter ablation as a first-line approach. However, the presence of structural heart diseases, the LA size, the type of AF, comorbidities and the need for long-term anticoagulant and antiarrhythmic therapy may determine the type and role of the PV ablation strategy. To develop PV ablation as a mainstream therapy for AF will require controlled, randomized studies in specific subgroups of the AF population.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine